Text
The findings of a recent study suggest that DNA damage-inducing microbial metabolites such as indolimines play a role in the development of colorectal cancer.
The findings of a recent study suggest that a specific strain of Subdoligranulum can drive the production of autoantibodies in rheumatoid arthritis.
Scientists identified a bacterium, Bacteroides xylanisolvens, that reduced gut nicotine concentrations in mice exposed to nicotine as well as the severity of NAFLD.
A recent study provides evidence for the beneficial effects of GMD and the gut commensal bacterium P. merdae against obesity-related atherosclerosis.
Important goal reached by the Novara-based pharmaceuticals company, specialised in the production and marketing of live biotherapeutic products.
Periodontitis might be associated with cognitive decline, suggesting a possible etiopathologic role in Alzheimer's disease.
The report of the main topics highlighted at the event on 12 October 2022 related to Probiotics, Prebiotics and the Microbiome.
The findings of a new research suggest that, in some people, microbial ethanol can contribute to the development of NAFLD.
Formal approval of BiomeBank’s first-generation donor derived microbiome-based therapy product, BIOMICTRA registered in the Australian Register of Therapeutic Goods
The findings of a new research may help to develop improved diagnostic or treatment approaches for pancreatic cancer.
